• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    France Healthcare Cold Chain Logistics Market

    ID: MRFR/HC/43351-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    France Healthcare Cold Chain Logistics Market Research Report By Mode of Delivery (Last-Mile Delivery, Hubs-to-Distributor), By Product (Vaccines, Biopharmaceuticals, Clinical Trial Materials), By Services (Transportation, Storage, Packaging, Labeling, Others), By End User (Hospitals Clinics, Pharmaceutical, Biopharmaceutical, Biotechnology Companies, Others) and By Temperature Range (Ambient, Refrigerated, Frozen, Cryogenic)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    France Healthcare Cold Chain Logistics Market Summary

    France Healthcare Cold Chain Logistics Market Trends

    The France Healthcare Cold Chain Logistics Market is witnessing significant trends driven by regulatory changes and an increasing emphasis on patient safety. With France's strong regulatory framework that mandates specific temperature control standards for pharmaceutical and biological products, logistics providers are increasingly adopting advanced technologies. These include real-time temperature monitoring systems, which enhance the traceability and reliability of temperature-sensitive shipments.

    This transition is spurred by the rising demand for vaccines and biopharmaceuticals, especially following the COVID-19 pandemic, which underscored the importance of efficient and reliable cold chain logistics.Furthermore, opportunities exist for companies to invest in infrastructure improvements, such as temperature-controlled warehouses and transportation fleets. The growing trend toward integrating Internet of Things (IoT) technology into logistics operations is opening up avenues for enhanced efficiency, minimizing waste, and ensuring the integrity of healthcare products.

    The French government's initiatives to promote innovation in the healthcare segment align with these opportunities, paving the way for new players and investment into the cold chain sector. In recent times, the focus on sustainability has grown, with the demand for eco-friendly packaging and energy-efficient transport options on the rise.France's commitment to reducing carbon emissions is driving logistics providers to adopt greener practices. This trend is supported by local policies encouraging sustainable operations in the healthcare sector.

    There is a substantial opportunity for companies willing to adapt their practices to meet these evolving consumer preferences and regulatory requirements, ensuring their positioning within the competitive landscape of the France Healthcare Cold Chain Logistics Market.

    France Healthcare Cold Chain Logistics Market Drivers

    Market Segment Insights

    France Healthcare Cold Chain Logistics Market Segment Insights

    Healthcare Cold Chain Logistics Market Mode of Delivery Insights

    The France Healthcare Cold Chain Logistics Market showcases a robust framework in the Mode of Delivery segment, which is vital in ensuring the integrity of temperature-sensitive healthcare products. This segment is characterized by key components such as Last-Mile Delivery and Hubs-to-Distributor. Last-Mile Delivery is an essential aspect, as it focuses on the final distance products travel from distribution centers to healthcare facilities or patients.

    This segment addresses strict regulations and requirements, ensuring that pharmaceuticals and biologics maintain appropriate temperature conditions until they reach their end-users.Hubs-to-Distributor represents another crucial facet of the delivery process, involving the transfer of goods from central logistics hubs to various distributors across the region. This stage plays a significant role in the efficiency and speed of the overall logistics chain, impacting how quickly healthcare products can be accessed by consumers. The importance of these segments cannot be overstated, as they facilitate timely access to critical healthcare solutions, especially during pandemics and health emergencies.

    Growing demand from the aging population in France and an increase in the prevalence of chronic diseases vedriven investment in these logistics segments.Moreover, advancements in technology, such as IoT tracking and temperature monitoring systems, are transforming operational efficiencies and enhancing the reliability of deliveries. The France Healthcare Cold Chain Logistics Market statistics point towards a sustained growth trajectory underpinned by the expanding healthcare infrastructure and innovative logistics solutions.

    Keeping pace with these evolving dynamics, companies are also focusing on sustainability practices within their delivery methods, seeking to minimize environmental impact while maintaining compliance with stringent regulations.As healthcare demands continue to rise, the Mode of Delivery segment remains a focal point for driving market growth and innovation in the healthcare logistics landscape of France. Ultimately, the delivery modes play fundamental roles in maintaining the quality of healthcare services, thereby reinforcing the critical nature of the cold chain logistics market in France.

    France Healthcare Cold Chain Logistics Market Segment

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Healthcare Cold Chain Logistics Market Product Insights

    The France Healthcare Cold Chain Logistics Market is significantly shaped by its product segment, which encompasses critical areas such as vaccines, biopharmaceuticals, and clinical trial materials. Vaccines are vital for disease prevention, and France has implemented robust vaccination programs, necessitating stringent cold chain management for effective distribution and storage. Biopharmaceuticals represent a rapidly growing sector, driven by advancements in biotechnology and personalized medicine, requiring precise temperature-controlled environments to maintain product integrity and efficacy.Clinical trial materials, essential for research and drug development, also demand efficient logistics to ensure timely delivery while preserving the quality of sensitive materials.

    The interplay of these sub-segments reflects the overall need for a reliable cold chain infrastructure in France, facilitating compliance with regulations and enhancing supply chain efficiency. As the healthcare landscape continues to evolve, investments in cold chain logistics are expected to rise, further underlining the importance of these product segments within the France Healthcare Cold Chain Logistics Market.

    Healthcare Cold Chain Logistics Market Services Insights

    The Services segment of the France Healthcare Cold Chain Logistics Market plays a critical role in ensuring that sensitive healthcare products are delivered and stored under optimal conditions. This segment encompasses key activities such as Transportation, Storage, Packaging, and Labeling, each contributing significantly to the integrity of temperature-sensitive products. Transportation services are vital, as they ensure timely delivery of pharmaceuticals and biologics, meeting the stringent regulations imposed in France. Storage solutions are equally important, providing controlled environments that uphold safety and efficacy.Packaging methods that maintain temperature and protect products from external factors are essential for compliance and marketability.

    Labeling also holds significance, as it ensures that all transported goods are easily identifiable and compliant with regulatory standards. The demand in this sector is driven by an expanding biopharmaceutical industry and an increasing focus on healthcare efficiency. Furthermore, the rise in e-commerce for pharmaceutical products in France creates opportunities for innovation in logistics services, especially in areas like last-mile delivery and temperature management solutions.Overall, these services are central to the proper functioning of the healthcare supply chain in France, reflecting the growing need for precision in the handling of healthcare products.

    Healthcare Cold Chain Logistics Market End User Insights

    The France Healthcare Cold Chain Logistics Market has a multifaceted End User segment comprising Hospitals Clinics, Pharmaceutical companies, Biopharmaceutical organizations, and Biotechnology firms among others. Hospitals Clinics play a vital role in ensuring the safe transport of temperature-sensitive medical supplies, such as vaccines and biologics, highlighting their significant impact on healthcare delivery.

    The Pharmaceutical segment is crucial due to the rising demand for effective cold chain solutions that extend the shelf life of products, thereby ensuring patient safety and compliance.Biopharmaceuticals and Biotechnology companies rely heavily on efficient cold chain logistics for the preservation of complex therapies, which require stringent temperature controls. Moreover, the Others category encompasses various emerging sectors that contribute to the diversification of the market.

    With an increasing emphasis on patient care and regulatory compliance in France, the importance of each segment within the Healthcare Cold Chain Logistics Market continues to grow, underpinned by advancements in technology and logistics practices.This diverse segmentation reflects the complexity and vital nature of cold chain logistics in maintaining the integrity of vital healthcare products across the region.

    Healthcare Cold Chain Logistics Market Temperature Range Insights

    The France Healthcare Cold Chain Logistics Market is highly influenced by the Temperature Range segment, encompassing various crucial categories such as Ambient, Refrigerated, Frozen, and Cryogenic. Each of these categories plays a pivotal role in ensuring the safety and efficacy of pharmaceutical products, vaccines, and biopharmaceuticals. Refrigerated transport is particularly significant, as it allows for the safe delivery of temperature-sensitive medications, which is critical in France's evolving healthcare landscape. The Frozen segment is vital for maintaining the integrity of products that require lower temperatures, ensuring they remain effective upon usage.

    Cryogenic storage and shipping further enhance the market's capabilities, allowing for the transport of specialized materials that require extreme cold. With increasing regulatory frameworks and advancements in cold chain technologies, the market's ability to meet stringent temperature requirements and improve product traceability will be essential. The segmentation of the France Healthcare Cold Chain Logistics Market reflects the diverse needs of the healthcare industry, emphasizing the importance of maintaining the cold chain for various pharmaceutical needs, thus driving market growth opportunities in the region.

    Regional Insights

    Key Players and Competitive Insights

    The France Healthcare Cold Chain Logistics Market is characterized by a competitive landscape that is continually evolving in response to advancements in technology, regulatory developments, and shifting consumer expectations. Companies operating in this market are primarily focused on maintaining the integrity of temperature-sensitive medical products, which include pharmaceuticals, biologics, and medical devices. The competitive dynamics are influenced by the need for compliance with stringent regulations imposed by health authorities, as well as the growing emphasis on improving supply chain visibility and efficiency.

    As the healthcare sector in France continues to expand, particularly in light of technological innovations such as IoT and AI, cold chain logistics providers are adapting their strategies to leverage these advancements, ensuring they meet the rising demands for quality and reliability.Cegelec is a prominent player in the France Healthcare Cold Chain Logistics Market, renowned for its strong technical capabilities and commitment to client service. The company has established a robust market presence through its comprehensive cold chain solutions that cater specifically to the healthcare sector.

    Strong points for Cegelec include its deep understanding of regulatory requirements and its ability to design customized logistics solutions that comply with stringent quality standards. The company has built a reliable network of temperature-controlled facilities and transportation options, allowing it to offer end-to-end logistics solutions that minimize risk and enhance the efficacy of distribution.

    Cegelec's experience in the market enables it to effectively respond to the challenges posed by the sensitive nature of healthcare products, underscoring its competitive edge in delivering high-quality service.Agility Logistics plays a significant role in the France Healthcare Cold Chain Logistics Market, offering a suite of services tailored to the unique needs of the healthcare industry. The company specializes in temperature-controlled storage, transportation, and logistics solutions for pharmaceuticals and biologics, emphasizing a comprehensive approach to cold chain management.

    One of Agility Logistics' key strengths is its extensive network of strategically located facilities across France, which enables efficient distribution and rapid response times. Additionally, Agility's investments in advanced tracking technologies allow for enhanced visibility throughout the supply chain, ensuring product integrity from origin to destination. The company has also engaged in strategic partnerships and acquisitions, strengthening its market position and expanding its capabilities in cold chain logistics to better serve the healthcare sector in France. Through these initiatives, Agility Logistics continues to solidify its reputation as a leader in the healthcare cold chain logistics landscape.

    Industry Developments

    Recent developments in the France Healthcare Cold Chain Logistics Market have been significant, primarily driven by the ongoing demand for temperature-sensitive healthcare products, including vaccines and biologics. Companies like DHL Supply Chain and UPS continue to expand their cold chain capabilities, enhancing their footprint in France to meet the growing need for efficient transportation and storage solutions. In terms of acquisitions, in March 2023, Agility Logistics acquired a local firm specializing in cold chain logistics, enhancing its operational capacity in France.

    Kuehne + Nagel has also reported an increase in market valuation due to strategic investments in refrigerated storage facilities, improving their service offerings within the region. Additionally, geopolitical trends and recent health crises have catalyzed growth, leading to a predicted expansion in the cold chain logistics sector. In the past few years, the sector witnessed notable shifts, including the partnership between Geodis and Cold Chain Technologies in July 2022 to enhance temperature-controlled distribution. The French government has committed to supporting the pharmaceutical supply chain through regulatory measures, further bolstering the healthcare cold chain logistics market's robustness and operational efficiency.

    Market Segmentation

    Outlook

    • Ambient
    • Refrigerated
    • Frozen
    • Cryogenic

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 168.75(USD Million)
    MARKET SIZE 2024 176.25(USD Million)
    MARKET SIZE 2035 376.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 7.131% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Cegelec, Agility Logistics, Panalpina, DHL Supply Chain, Geodis, Kuehne + Nagel, Maersk, Transports Deum, Pharma Logistics, Cold Chain Technologies, XPO Logistics, UPS, FedEx, TSE Express, DB Schenker
    SEGMENTS COVERED Mode of Delivery, Product, Services, End User, Temperature Range
    KEY MARKET OPPORTUNITIES Digital tracking solutions, Biopharma temperature control, Vaccine logistics optimization, Sustainable packaging innovations, Regulatory compliance consulting
    KEY MARKET DYNAMICS Rising demand for temperature-sensitive products, Regulatory compliance for healthcare logistics, Increasing need for personalized medicine, Growth in e-commerce pharmaceutical delivery, Advancements in cold chain technology
    COUNTRIES COVERED France

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the estimated market size of the France Healthcare Cold Chain Logistics Market in 2024?

    The France Healthcare Cold Chain Logistics Market is estimated to be valued at 176.25 million USD in 2024.

    What is the projected market size for the France Healthcare Cold Chain Logistics Market by 2035?

    By 2035, the market is projected to reach a value of 376.0 million USD.

    What is the expected compound annual growth rate (CAGR) of the France Healthcare Cold Chain Logistics Market from 2025 to 2035?

    The market is expected to grow at a CAGR of 7.131% from 2025 to 2035.

    What are the values for Last-Mile Delivery and Hubs-to-Distributor in 2024?

    In 2024, Last-Mile Delivery is valued at 85.0 million USD, while Hubs-to-Distributor is valued at 91.25 million USD.

    What are the estimated market values for Last-Mile Delivery and Hubs-to-Distributor by 2035?

    By 2035, Last-Mile Delivery is expected to reach 178.0 million USD and Hubs-to-Distributor is anticipated to be valued at 198.0 million USD.

    Who are the major players in the France Healthcare Cold Chain Logistics Market?

    Key players in the market include Cegelec, Agility Logistics, Panalpina, DHL Supply Chain, Geodis, Kuehne + Nagel, and Maersk among others.

    What is driving the growth of the France Healthcare Cold Chain Logistics Market?

    The growth is driven by increasing demand for temperature-sensitive pharmaceuticals and advancements in logistics technologies.

    How has the current global scenario affected the France Healthcare Cold Chain Logistics Market?

    The ongoing global scenario has heightened the importance of efficient cold chain logistics in maintaining the integrity of healthcare supplies.

    What are the challenges faced by the France Healthcare Cold Chain Logistics Market?

    Challenges include managing compliance with regulations and the need for continuous temperature monitoring during transport.

    What are the future opportunities for the France Healthcare Cold Chain Logistics Market?

    Future opportunities include leveraging automation technologies and expanding partnerships within the healthcare supply chain.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. France Healthcare Cold Chain Logistics Market, BY Mode of Delivery (USD Million)
    45. Last-Mile Delivery
    46. Hubs-to-Distributor
    47. France Healthcare Cold Chain Logistics Market, BY Product (USD Million)
    48. Vaccines
    49. Biopharmaceuticals
    50. Clinical Trial Materials
    51. France Healthcare Cold Chain Logistics Market, BY Services (USD Million)
    52. Transportation
    53. Storage
    54. Packaging
    55. Labeling
    56. Others
    57. France Healthcare Cold Chain Logistics Market, BY End User (USD Million)
    58. Hospitals Clinics
    59. Pharmaceutical
    60. Biopharmaceutical
    61. Biotechnology Companies
    62. Others
    63. France Healthcare Cold Chain Logistics Market, BY Temperature Range (USD Million)
    64. Ambient
    65. Refrigerated
    66. Frozen
    67. Cryogenic
    68. Competitive Landscape
    69. Overview
    70. Competitive Analysis
    71. Market share Analysis
    72. Major Growth Strategy in the Healthcare Cold Chain Logistics Market
    73. Competitive Benchmarking
    74. Leading Players in Terms of Number of Developments in the Healthcare Cold Chain Logistics Market
    75. Key developments and growth strategies
    76. New Product Launch/Service Deployment
    77. Merger Acquisitions
    78. Joint Ventures
    79. Major Players Financial Matrix
    80. Sales and Operating Income
    81. Major Players RD Expenditure. 2023
    82. Company Profiles
    83. Cegelec
    84. Financial Overview
    85. Products Offered
    86. Key Developments
    87. SWOT Analysis
    88. Key Strategies
    89. Agility Logistics
    90. Financial Overview
    91. Products Offered
    92. Key Developments
    93. SWOT Analysis
    94. Key Strategies
    95. Panalpina
    96. Financial Overview
    97. Products Offered
    98. Key Developments
    99. SWOT Analysis
    100. Key Strategies
    101. DHL Supply Chain
    102. Financial Overview
    103. Products Offered
    104. Key Developments
    105. SWOT Analysis
    106. Key Strategies
    107. Geodis
    108. Financial Overview
    109. Products Offered
    110. Key Developments
    111. SWOT Analysis
    112. Key Strategies
    113. Kuehne + Nagel
    114. Financial Overview
    115. Products Offered
    116. Key Developments
    117. SWOT Analysis
    118. Key Strategies
    119. Maersk
    120. Financial Overview
    121. Products Offered
    122. Key Developments
    123. SWOT Analysis
    124. Key Strategies
    125. Transports Deum
    126. Financial Overview
    127. Products Offered
    128. Key Developments
    129. SWOT Analysis
    130. Key Strategies
    131. Pharma Logistics
    132. Financial Overview
    133. Products Offered
    134. Key Developments
    135. SWOT Analysis
    136. Key Strategies
    137. Cold Chain Technologies
    138. Financial Overview
    139. Products Offered
    140. Key Developments
    141. SWOT Analysis
    142. Key Strategies
    143. XPO Logistics
    144. Financial Overview
    145. Products Offered
    146. Key Developments
    147. SWOT Analysis
    148. Key Strategies
    149. UPS
    150. Financial Overview
    151. Products Offered
    152. Key Developments
    153. SWOT Analysis
    154. Key Strategies
    155. FedEx
    156. Financial Overview
    157. Products Offered
    158. Key Developments
    159. SWOT Analysis
    160. Key Strategies
    161. TSE Express
    162. Financial Overview
    163. Products Offered
    164. Key Developments
    165. SWOT Analysis
    166. Key Strategies
    167. DB Schenker
    168. Financial Overview
    169. Products Offered
    170. Key Developments
    171. SWOT Analysis
    172. Key Strategies
    173. References
    174. Related Reports
    175. France Healthcare Cold Chain Logistics Market SIZE ESTIMATES & FORECAST, BY MODE OF DELIVERY, 2019-2035 (USD Billions)
    176. France Healthcare Cold Chain Logistics Market SIZE ESTIMATES & FORECAST, BY PRODUCT, 2019-2035 (USD Billions)
    177. France Healthcare Cold Chain Logistics Market SIZE ESTIMATES & FORECAST, BY SERVICES, 2019-2035 (USD Billions)
    178. France Healthcare Cold Chain Logistics Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)
    179. France Healthcare Cold Chain Logistics Market SIZE ESTIMATES & FORECAST, BY TEMPERATURE RANGE, 2019-2035 (USD Billions)
    180. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    181. ACQUISITION/PARTNERSHIP
    182. MARKET SYNOPSIS
    183. FRANCE HEALTHCARE COLD CHAIN LOGISTICS MARKET ANALYSIS BY MODE OF DELIVERY
    184. FRANCE HEALTHCARE COLD CHAIN LOGISTICS MARKET ANALYSIS BY PRODUCT
    185. FRANCE HEALTHCARE COLD CHAIN LOGISTICS MARKET ANALYSIS BY SERVICES
    186. FRANCE HEALTHCARE COLD CHAIN LOGISTICS MARKET ANALYSIS BY END USER
    187. FRANCE HEALTHCARE COLD CHAIN LOGISTICS MARKET ANALYSIS BY TEMPERATURE RANGE
    188. KEY BUYING CRITERIA OF HEALTHCARE COLD CHAIN LOGISTICS MARKET
    189. RESEARCH PROCESS OF MRFR
    190. DRO ANALYSIS OF HEALTHCARE COLD CHAIN LOGISTICS MARKET
    191. DRIVERS IMPACT ANALYSIS: HEALTHCARE COLD CHAIN LOGISTICS MARKET
    192. RESTRAINTS IMPACT ANALYSIS: HEALTHCARE COLD CHAIN LOGISTICS MARKET
    193. SUPPLY / VALUE CHAIN: HEALTHCARE COLD CHAIN LOGISTICS MARKET
    194. HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY MODE OF DELIVERY, 2024 (% SHARE)
    195. HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY MODE OF DELIVERY, 2019 TO 2035 (USD Billions)
    196. HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY PRODUCT, 2024 (% SHARE)
    197. HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY PRODUCT, 2019 TO 2035 (USD Billions)
    198. HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY SERVICES, 2024 (% SHARE)
    199. HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY SERVICES, 2019 TO 2035 (USD Billions)
    200. HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY END USER, 2024 (% SHARE)
    201. HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY END USER, 2019 TO 2035 (USD Billions)
    202. HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE RANGE, 2024 (% SHARE)
    203. HEALTHCARE COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE RANGE, 2019 TO 2035 (USD Billions)
    204. BENCHMARKING OF MAJOR COMPETITORS

    France Healthcare Cold Chain Logistics Market Segmentation

    • Healthcare Cold Chain Logistics Market By Mode of Delivery (USD Million, 2019-2035)

      • Last-Mile Delivery
      • Hubs-to-Distributor
    • Healthcare Cold Chain Logistics Market By Product (USD Million, 2019-2035)

      • Vaccines
      • Biopharmaceuticals
      • Clinical Trial Materials
    • Healthcare Cold Chain Logistics Market By Services (USD Million, 2019-2035)

      • Transportation
      • Storage
      • Packaging
      • Labeling
      • Others
    • Healthcare Cold Chain Logistics Market By End User (USD Million, 2019-2035)

      • Hospitals Clinics
      • Pharmaceutical
      • Biopharmaceutical
      • Biotechnology Companies
      • Others
    • Healthcare Cold Chain Logistics Market By Temperature Range (USD Million, 2019-2035)

      • Ambient
      • Refrigerated
      • Frozen
      • Cryogenic

    No infographic available

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials